Biolife stock.

Biolife Solutions story: Exercise or conversion by Karen Foster of 16332 shares of Biolife Solutions subject to Rule 16b-3 and other headlines for Biolife Solutions Please click here if you are not redirected within a few seconds.Chg %. Market Cap. Evogene Ltd. -1.07%. $30.17M. BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full …Open 18.44. Day High 18.95. Day Low 18.17. Prev Close 18.25. 52 Week High 26.96. 52 Week High Date 09/08/22. 52 Week Low 10.40. 52 Week Low Date 05/12/22. Market Cap 812.385M.WebWe are revolutionizing regenerative medicine, biobanking and drug discovery by increasing the viability of biologics. BioLife Solutions is a class-defining cell and gene therapy bioproduction tools and services company. Our solutions give life science companies and clinical researchers significant improvement in shelf life and post-preservation ...Historical daily share price chart and data for BioLife Solutions since 1992 adjusted for splits and dividends. The latest closing stock price for BioLife Solutions as of December 01, …

Nov 3, 2023 · Bothell-based cold storage company BioLife Solutions Inc. (Nasdaq: BLFS) has raised $10.4 million through a private placement to New York City-based investment firm Casdin Capital. Nov 16, 2023 · On November 15, 2023, BioLife Solutions, Inc. (NASDAQ:BLFS) stock closed at $12.34 per share. One-month return of BioLife Solutions, Inc. (NASDAQ:BLFS) was 10.28%, and its shares lost 41.93% of ...

Cold Chain Logistics Stocks: BioLife vs Cryoport. Regenerative Medicine. September 20. 2022. 9 mins read. A few months ago, we held a cage match between two of the leading gene-editing stocks. Basically, it ended in a draw, leaving us with a mini portfolio in this potentially lucrative but extremely volatile life sciences /nanotech market.

BLFE: Biolife Sciences Inc - Stock Price, Quote and News - CNBCWebPosted 3:27:21 PM. By clicking the "Apply" button, I understand that my employment application process with Takeda…See this and similar jobs on LinkedIn.Get the latest BioLife Sciences Inc. (BLFE) stock news and headlines to help you in your trading and investing decisions. In today’s fast-paced world, maintaining a healthy lifestyle can be challenging. However, thanks to technological advancements, we now have access to various tools and applications that can help us track our nutritional intake and make info...Get the latest BioLife Solutions, Inc. (BLFS) stock quote, history, news and other vital information to help you with your stock trading and investing. See the company's performance outlook, earnings date, dividend and yield, fair value, ratings and more.

Dec 1, 2023 · Dividends. A high-level overview of BioLife Solutions, Inc. (BLFS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

BioLife Sciences Inc. (OTC:BLFE) is a commercialization accelerator of innovative and disruptive technologies for the healthcare, beauty and food & beverage industry sectors. One of BioLife Science’s core building block strategies is to develop, partner and assist innovative companies with commercialization of leading-edge technologies. KNOW ...Web

Notes to Financial Statements Business Combination Disclosure [Text Block] 15. Acquisitions Sexton acquisition General terms and effects On August 9, 2021, BioLife entered into an Agreement and Plan of Merger (the “Sexton Merger Agreement”) with BLFS Merger Sub, Inc., a Delaware corporation (“Sexton Merger Sub”), Fortis Advisors LLC, in …Nov 9, 2023 · BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets. Mar 2, 2023 · BOTHELL - BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ('CGT') and broader biopharma markets, today announced the launch of Ultraguard, the first ever non-toxic, non-hazardous and non-flammable -70-degreeC phase change material ('PCM'), for ultra-low temperature (ULT) protection. Nasdaq -23.34(-0.16%) Russell 2000 +10.01 BioLife Solutions, Inc. (BLFS) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 14.14 +0.57 (+4.20%) …BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.WebWall Street Stock Market & Finance report, prediction for the future: You'll find the BioLife Sciences share forecasts, stock quote and buy / sell signals below. According to present data BioLife Sciences's BLFE shares and potentially its market environment have been in bearish cycle last 12 months (if exists).

Dec 4, 2023 · BioLife Solutions Stock Up 7.1 %. Shares of NASDAQ BLFS opened at $13.25 on Monday. BioLife Solutions, Inc. has a one year low of $8.92 and a one year high of $26.89. The company has a debt-to ... If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.BioLife issued 6,646,870 shares of common stock in exchange for 100% of the outstanding shares of Stirling. BioLife management has provided guidance for Stirling's 2021 post-closing revenue contribution to be $35 million to $37 million , with total 2021 revenue of $101 million to $110 million .Aug 8, 2023 · BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $1.71 per share a year ago. Thinly traded micro cap BioLife Solutions (NASDAQ:BLFS -15.6%) has increased its stake in SAVSU Technologies to 44% with a $5M investment.BOTHELL, Wash., July 27, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's second quarter financial results will be released after market close on Tuesday, August …BioLife Solutions is trading near 52-week lows as its growth story has floundered and profitability remains uncertain. Learn why I rate BLFS stock a hold.

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Dec 4, 2023 · Rhumbline Advisers decreased its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 8.1% in the second quarter, Holdings Channel.com reports. The institutional investor owned 80,251 shares of the medical equipment provider’s stock after selling 7,097 shares during the period. Rhumbline Advisers’ holdings in BioLife Solutions were worth $1,774,000 as of its most recent […]

Investors. Overview. Financial Highlights. Quarterly Results. Stock Information. Securities Report & Form 20-F. IR Events. We bring our values to life through actions based on Patient-Trust-Reputation-Business, in that order. We believe that if we focus first on Patients, Trust and Reputation, we know we will build a sustainable and high ...BIOLIFE : B Riley Raises BioLife Solutions' PT to $61 from $35.50 After Q4 Revenue Beats Street, Announces Stirling Ultracold Deal; Keeps Buy Rating 2021: MT BIOLIFE : Maxim Adjusts Price Target on BioLife Solutions to $60 From $40, Maintains Buy Rating 2021: MTWhen it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Analysis of Biolife Solutions Beneish M Score for 2022 including historical trends for the last ten yearsBIOLIFE SOLUTIONS INC NEW COM STK (DE); BioLife Solutions, Inc. BioLife Solutions, Inc. View SEC Filings ... Stock Lookup. Enter stock name: use * for wildcard.BioLife Solutions Inc (NASDAQ:BLFS). 12.77. Delayed Data. As of Nov 17. +0.81 / + ... Most stock quote data provided by BATS. Market indices are shown in real ...

Biolife Sciences Inc (BLFE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.

Nov 3, 2023 · Bothell-based cold storage company BioLife Solutions Inc. (Nasdaq: BLFS) has raised $10.4 million through a private placement to New York City-based investment firm Casdin Capital. The BioLife Solutions stock price gained 3.76% on the last trading day (Friday, 24th Nov 2023), rising from $13.57 to $14.08. During the last trading day the stock fluctuated 11.10% from a day low at $12.79 to a day high of $14.21. The price has risen in 6 of the last 10 days and is up by 23.62% over the past 2 weeks.WebDec 1, 2023 · BioLife Solutions (NASDAQ:BLFS) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock?We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking. Aug 30, 2021 · 1) Consists of 10,735,334 shares of common stock being registered for resale by selling stockholders. The shares consist of (i) 611,683 shares issued in October 2020 in connection with the registrant’s acquisition of SciSafe Holdings, Inc., which had not been previously registered, (ii) 2,956,679 shares held by Casdin Partners Master Fund, LP (“Casdin”) which were acquired in various ... Analysis of Biolife Solutions Piotroski F Score for 2022 including historical trends for the last ten yearsFind the latest BioLife Sciences Inc. (BLFE) stock quote, history, news and other vital information to help you with your stock trading and investing.Biolife Solutions Inc stock received a consensus recommendation rating of a Buy, based on a mean score of 1.25. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended BLFS as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight.Roderick de Greef appointed Chairman and Chief Executive Officer bringing 20+ years of prior BioLife experience. Garrie Richardson appointed Chief Revenue Officer. Preliminary Q3 revenue of $33.3 million and expect 2023 revenue at the low end of the previously announced guidance range . BOTHELL, Wash., Oct. 19, 2023 /PRNewswire/ - …WebBioLife Solutions, Inc. (“BioLife”, “us”, “we”, “our”, or the “Company”) is a developer, manufacturer, and supplier of a portfolio of bioproduction tools and services including proprietary biopreservation media, automated cell processing fill machines, closed system cryogenic vials, human platelet lysate (“hPL”) growth ...Nov 16, 2023 · On November 15, 2023, BioLife Solutions, Inc. (NASDAQ:BLFS) stock closed at $12.34 per share. One-month return of BioLife Solutions, Inc. (NASDAQ:BLFS) was 10.28%, and its shares lost 41.93% of ...

On August 9, 2021, BioLife entered into an Agreement and Plan of Merger (the “Sexton Merger Agreement”) with BLFS Merger Sub, Inc., a Delaware corporation ... As consideration for the Sexton Merger (the “Sexton Merger Consideration”), holders of common stock, preferred stock and options of Sexton, other than the Company …Discover historical prices for BLFE stock on Yahoo Finance. View daily, weekly or monthly format back to when BioLife Sciences Inc. stock was issued.BioLife Sciences Inc. (“BioLife" or the "Company") (OTCPK: BLFE) specializes in moving innovative products from the lab or small-scale production. BLFE : 0.0001 (unch) BioLife Sciences Retains GS Whitney & Co for Corporate Relations Globe Newswire - Wed Aug 3, 2022. HENDERSON, NV, Aug. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife ...Instagram:https://instagram. washington state short term health insurancebest platform to trade forexstock neonhess gasoline toy truck Under the terms of the agreement, BioLife will pay $15 million in cash and $15 million in newly issued shares of BioLife common stock for 100% of the outstanding shares of SciSafe. SciSafe's shareholders are also eligible over the next four years to receive up to 626,000 additional shares of BioLife common stock based on the achievement of ...Biolife Solutions Return On Asset is currently at (5.67)%. Return on Asset or ROA shows how effective is the management of the Biolife Solutions in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of Biolife Solutions as well as to understand management … reliant holdingsnasdaq lunr See the latest Biolife Sciences Inc stock price (BLFE:PINX), related news, valuation, dividends and more to help you make your investing decisions. value of 1971 half dollar coin BioLife was founded as Trans Time Medical Products in 1987 and went public in 1989, raising net proceeds of $4.6 million at $105 per share (after giving effect to 1-for-five (2000) and 1-for-14 ...BLFE | Complete BioLife Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. BioLife Solutions (NASDAQ:BLFS) is an emerging life sciences company which benefits from a large biopreservation media platform and several other product lines.It currently has a $25 million ...